Targeting the epidermal growth factor receptor for head and neck cancer chemopreventionMAK, Milena P; WILLIAM, William N.Oral oncology (1997). 2014, Vol 50, Num 10, pp 918-923, issn 1368-8375, 6 p.Article

Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell CarcinomaZHONG, Lai-Ping; ZHANG, Chen-Ping; WANG, Li-Zhen et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 744-751, issn 0732-183X, 8 p.Article

Epidermal Growth Factor Receptor Inhibitors for Treatment of Orbital Squamous Cell CarcinomaEL-SAWY, Tarek; SABICHI, Anita L; MYERS, Jeffrey N et al.Archives of ophthalmology (1960). 2012, Vol 130, Num 12, pp 1608-1611, issn 0003-9950, 4 p.Article

Necrotizing fasciitis as a late complication of multimodal treatment for locally advanced head and neck cancer : A case reportMALUF, Fernando C; WILLIAM, William N; RIGATO, Otelo et al.Head & neck. 2007, Vol 29, Num 7, pp 700-704, issn 1043-3074, 5 p.Article

Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective TrialKIES, Merrill S; CHRISTOPHER HOLSINGER, Floyd; BYERS, Lauren et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 8-14, issn 0732-183X, 7 p.Article

Randomized Trial of 13 -as Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral PremalignancyPAPADIMITRAKOPOULOU, Vassiliki A; LEE, J. Jack; LIPPMAN, Scott M et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 599-604, issn 0732-183X, 6 p.Article

Phase 2 Study of Carboplatin, Docetaxel, and Bevacizumab as Frontline Treatment for Advanced Nonsmall-Cell Lung CancerWILLIAM, William N; KIES, Merrill S; FOSSELLA, Frank V et al.Cancer. 2010, Vol 116, Num 10, pp 2401-2408, issn 0008-543X, 8 p.Article

Weekly Alternating Therapy With Irinotecan Plus Cisplatin and Etoposide Plus Cisplatin in the Treatment of Patients With Extensive Small Cell Lung CarcinomaWILLIAM, William N; UYEKI, James; JOHNSON, Faye M et al.Cancer. 2010, Vol 116, Num 10, pp 2409-2415, issn 0008-543X, 7 p.Article

A Phase 2 Study of Cetuximab in Combination With Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Nonsmall Cell Lung CancerKIM, Edward S; MAUER, Ann M; WILLIAM, William N et al.Cancer. 2009, Vol 115, Num 8, pp 1713-1722, issn 0008-543X, 10 p.Article

Revisiting Stage IIIB and IV Non-small Cell Lung Cancer: Analysis of the Surveillance, Epidemiology, and End Results DataWILLIAM, William N; LIN, Heather Y; LEE, J. Jack et al.Chest (American College of Chest Physicians). 2009, Vol 136, Num 3, pp 701-709, issn 0012-3692, 9 p.Article

Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant LesionsPAPADIMITRAKOPOULOU, Vassiliki A; WILLIAM, William N; NATHAN, Cherie-Ann et al.Clinical cancer research. 2008, Vol 14, Num 7, pp 2095-2101, issn 1078-0432, 7 p.Article